Synthetic compounds and molecules derived from natural products belonging to Brazil’s biodiversity are being screened by teams at the Center for Innovation in Biodiversity and Drug Discovery.
Initiative supported by FAPESP, USP, UNICAMP and global partners sets out to discover new molecules against tropical parasitic diseases. Its aim is to develop effective and affordable drugs.
Glaucius Oliva speaks at FAPESP Week London about the line of work of the Center for Research and Innovation in Biodiversity and Drug Discovery and how the UK collaboration helps developing structural biology in Brazil.
Few novel drugs have been developed to treat neglected diseases in recent decades, Brazilian researchers warn.
The compound called GA-Hecate also acts on bacteria, fungi and cancer cells and will be tested against Zika and yellow fever viruses.
Molecule designed by the Center for Research and Innovation in Biodiversity and Drug Discovery killed malaria parasite in mice and in vitro culture.
Researchers seek to identify target biological receptors and discover candidate molecules for new drugs